In the chick embryo, two methods are now used for studying the developmental role of genes by loss-of-function approaches: vector-based shRNA and morpholino oligonucleotides. Both have the advantage that loss-of-function can be conducted in a spatially and temporally controlled way by focal electroporation. Here, we compare these two methods.
Introduction
Sequence specific knock-down strategies using morpholino oligonucleotides and short-interfering RNAs (siRNA) have proven to be powerful tools to study gene function in different organisms. However, sequence-independent off-target effects have been reported in mammals and fish to cause developmental defects including wide spread cell death (Ekker and Larson, 2001; Robu et al., 2007; Scacheri et al., 2004) . The chick embryo is a well established developmental model system, which lends itself particularly well to the introduction of DNA constructs by electroporation into specific tissues to perform temporally and spatially controlled gain-and lossof-function studies (Funahashi et al., 1999; Katahira and Nakamura, 2003; Muramatsu et al., 1997; Nakamura et al., 2004 Nakamura et al., , 2000 .
For loss-of-function, electroporation of morpholinos (Kos et al., 2003; Papanayotou et al., 2008; Sheng et al., 2003; Tucker, 2001; Voiculescu et al., 2007) or expression of dominant negative DNA constructs (Becker et al., 2001; Bel-Vialar et al., 2002; Chen and Cepko, 2002) have both been successful. Recently, methods for vector-based RNA interference have been described, requiring small amounts of DNA to be introduced into tissues, while allowing long lasting and stable expression 0925-4773/$ -see front matter Ó 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2008.08.005 of the short-interfering RNA (Bron et al., 2004; Das et al., 2006; Katahira and Nakamura, 2003) . One approach in particular used a system to express short-hairpin RNA molecules, which resemble naturally occurring microRNA (miRNA) and appear to be processed efficiently by endogenous enzymes to yield siRNA and gene silencing (Das et al., 2006) . Most studies using siRNA approaches generally investigate processes that occur after the 10-somite stage, while morpholino knock-down has most successfully been used in young embryos before or around primitive streak stages.
To establish a reliable loss-of-function strategy in young chick embryos we compared the vector-based approach using short-hairpin RNAs (shRNA; in particular pRFPRNAi; Das et al., 2006) with morpholinos. We were surprised to find that vectors targeting Eya2, Pax2 and Notch1 as well as control vectors targeting GFP, cause identical morphological phenotypes including the absence of cranial placodes and neural tube closure defects, and mis-regulation of neural, preplacodal, otic and olfactory placode markers. In addition, elevated levels of apoptosis are observed. These non-specific effects appear to be independent of the miRNA pathway member Dicer or of activation of the interferon pathway, but seem to be due to activation of p53 target genes. To determine whether all antisense methods suffer from the same shortcomings, we carried out similar experiments using morpholinos and find that they cause efficient and specific knock-down, but do not show non-specific side-effects. Our data suggest that using morpholinos is the preferential approach for gene knock-down in early (HH4-10) chick embryos.
Results

pRFPRNAi gene silencing vectors affect otic morphology and gene expression
Because of our interest in ectodermal patterning and sensory placode formation, we focussed on designing knockdown strategies for genes that are expressed in the placode territory (Eya2) and the otic placode (Pax2). We started by using shRNA expression vectors pRFPRNAi (Das et al., 2006) and used the otic placode, which becomes morphologically discernible at stage HH10, as a read out.
The Eya2-targeting vector was introduced into stage HH5-6 embryos. Embryos were incubated overnight, harvested and tested for Pax2 expression as the earliest otic marker (Groves and Bronner-Fraser, 2000) . RFP + cells expressing the Eya2 silencing vector have reduced Pax2 expression and otic placode morphology is severely disrupted (6/6; Fig. 1A , A 0 and a). To test the efficiency of the silencing vector, we performed in situ hybridisation using a 3 0 UTR probe for Eya2.
Surprisingly, expression of the Eya2 silencing vector causes up-rather than down-regulation of the transcript (6/7; Fig. 1B , B 0 and b). This unexpected result could be caused by off-target effects of the Eya2-target sequence in the silencing vector. To test this, we introduced silencing vectors targeting the otic specific genes Pax2 and cNotch1 (Adam et al., 1998; Daudet and Lewis, 2005; Groves and Bronner-Fraser, 2000) . The Pax2 silencing vector causes disruption of otic cup morphology and only few cells retain expression of Pax2 (n = 19/19; Fig. 1C and C 0 ; Table 1 ) or the otic markers BMP7 and GATA3 (13/13 and 10/10, respectively; not shown). A similar effect is observed when cNotch1 is targeted: cNotch1 expression is reduced (6/6; Fig. 1D and D 0 ), Pax2 expression (6/ 8; Fig. 1E and E 0 ) and otic morphology is lost (Fig. 1e ).
Although these effects may suggest an early role for both genes in otic development, the loss of Pax2 transcripts and the otic placode after pRFPRNAi cNotch1 expression is unexpected, because previous studies showed that Notch inhibition by the c-secretase inhibitor DAPT leaves otic structures largely unaffected (Abello et al., 2007) . Furthermore, the consequences of targeting Pax2 and cNotch1 strongly resemble the effects of the Eya2 silencing vector. Consistent with this, we also observe an up-regulation of Eya2 after pRFPRNAi Pax2 expression (14/14; not shown).
The above results suggest that the effects of pRFPRNAi vectors are non-specific. To test this, the presumptive otic ectoderm on one side of the embryo was electroporated with a vector targeting GFP (Das et al., 2006) together with pCAb-IRES-GFP (driving GFP ubiquitously). The contralateral side of the same embryo received pCAb-IRES-GFP only (Fig. 1F) . The side expressing GFP alone contains fluorescent cells ( Table 1 ) or cNotch1 (0/5; not shown) expression is detected and otic morphology is lost completely (Fig. 1g) . In contrast, neither misexpression of vectors encoding GFP or RFP (n P 40 each) nor coexpression of both fluorescent proteins impaired otic development (n = 5 using pCAGGS vectors; n P 60 using pCAb-IRES vectors).
To rule out the possibility that the phenotypes observed are specific to otic markers and morphology, we investigated whether the silencing control vector pRFPRNAi GFP also alters the expression of preplacodal, neural plate and placode markers (Table 1) . We observe ectopic expression of Sox3 (14/19; when using a full length -rather than a 3 0 UTR-antisense probe ( Fig. 2A , A 0 and a). We cannot fully explain the discrepancy between the results when using two different Eya2 probes. We can rule out hybridisation of the 3 0 UTR probe to sequences in the electroporation vector: probes for Dlx5 3 0 UTR, Eya2 FL and 3 0 UTR, GnRH1, cNotch1, Pax2 3 0 UTR and FL, Sox2 and Sox3 were synthesised using the same plasmid template and include the same or similar sequences between the RNA polymerase promoter and the multiple cloning site of the template vector. Following pRFPRNAi electroporation, only some of these genes are up-regulated, while others are not. This excludes the possibility that the results are due to binding of the probes to the vector sequences. One possible explanation is that by introducing the silencing vectors short transcripts are created to which the shorter Eya2 3 0 UTR, but not the longer Eya2 FL probe can bind. All phenotypes described are independent of the silencing vector concentration being still observed with as little as 300 ng/ll vector. At this concentration vector-based RFP expression can barely be detected (Fig. 2E ).
Morpholino oligonucleotides do not cause non-specific effects
The above results suggest that pRFPRNAi vectors cause non-specific effects. To test whether this is the case for other antisense methods for knocking-down gene expression, we designed two morpholinos targeting intron-exon boundaries of Eya2 and two morpholinos targeting Pax2. Both Eya2 morpholinos were electroporated simultaneously into stage HH4-5 embryos, targeting the presumptive otic epithelium (Garcia-Martinez et al., 1993; Streit, 2002) . Their efficiency and specificity was confirmed by RT-PCR of electroporated tissues (Fig. 3A) . Neither morpholinos targeting Eya2 (n = 18) nor control (n = 14) morpholinos affect the expression of Pax2 or otic morphology (Fig. 3B) . Electroporation of the Pax2 of Pax2 leads to thinning of the otic placode suggesting that Pax2 may be required for its normal morphology. We expanded this analysis to other molecular markers and find that, unlike misexpression of pRFPRNAi vectors, electroporation of Eya2 or Pax2 morpholinos does not lead to ectopic up-regulation of Eya2 (Eya2-MO: n = 9; Pax2-MO: n = 8), Six1 (Eya2-MO: n = 15; Pax2-MO: n = 7), Pax6 (Eya2-MO: n = 10; Pax2-MO: n = 4), Six4 (Eya2-MO: n = 8) or Sox3 (Pax2-MO: n = 6; Fig. 3C and C 0 ). Electroporation of different gene silencing vectors causes ectopic expression and/or loss of preplacodal, placodal or neural markers. These effects are not observed when morpholinos or vectors ubiquitously expressing GFP and/or RFP are electroporated. Ab, antibody; * the apparent loss of Sox2 expression is due to impaired neural tube closure. Unrelated cell death refers to embryos, where elevated apoptosis was observed outside the electroporated area.
Taken together, the above results indicate that morpholinos can be used for specific knock-down of gene function in early chick embryos, whereas pRFPRNAi vectors cause nonspecific effects including up-and down-regulation of head ectoderm markers and defects in otic placode formation.
Expression of Dicer, Drosha and Argonaute2
The RNA interference system used allows optimal processing of the expressed transcripts by the endoribonucleases Drosha and Dicer (Das et al., 2006) , which should yield better silencing efficiency than conventional RNAi approaches (Chang et al., 2006) . If these enzymes are not expressed in relevant tissues, the overexpressed transcripts may be processed inappropriately or not at all, which in turn can result in unspecific cellular responses (Sledz et al., 2003) . To test whether this might be the cause of the non-specific effects observed, we analysed the expression patterns of both endoribonucleases and a component of the RNA-induced silencing complex (RISC) Argonaute2 (Hammond et al., 2001 ) between stages HH5 and HH12.
At neural plate stages (HH5-HH7, Fig. 4 ), Dicer and Drosha are strongly expressed throughout the ectoderm and weakly in the mesoderm, but appear to be absent from the endoderm ), in the neural tube with strongest expression dorsally (Fig. 4j 0 -j v0 ), in the optic vesicle (Fig. 4j  0 ) and in migrating neural crest cells (Fig. 4j 00 , j 0 0 0 and 4j v ). Furthermore, Dicer expression can also be seen in the ventral wall of the foregut (Fig. 4j 0 0 0 -j v ), the heart (Fig. 4j v ) and weakly in the dermomyotome (Fig. 4j v0 ), while it remains absent from the head mesoderm ( Fig. 4j 0 -j 0 0 0 ). In contrast, expression of both, Drosha
and Argonaute2 (not shown) can only be detected in the ventral and lateral neural tube, the optic stalks and weakly in the developing heart. Thus, while Dicer is expressed in all tissues where gene silencing vectors were tested, Drosha and Argonaute2 are only present in preplacodal ectoderm and the neural tube. It has been proposed that Dicer is the limiting factor in the RNAi pathway (Duchaine et al., 2006; Mikuma et al., 2004) and that it can associate with distinct classes of RISC to repress mRNA expression (Forstemann et al., 2007; Okamura et al., 2004; Tomari et al., 2007) . Hence, the finding that Dicer is expressed in the relevant tissues suggests that absence of this enzyme is not the reason for the non-specific effects of the gene silencing vectors.
2.4.
Side-effects caused by pRFPRNAi expression are independent of Dicer activity It is possible that transcripts from the ectopically expressed gene silencing vectors compete with endogenous small RNAs for processing by Dicer. If Dicer is the limiting factor in the RNAi pathway (Duchaine et al., 2006; Mikuma et al., 2004) , expression of the gene silencing vectors may lead to insufficient processing of endogenous substrates and the absence of miRNAs that normally keep specific genes silent. As a consequence, changes in unrelated transcripts may be observed. To test this hypothesis we investigated whether morpholino-mediated knock-down of Dicer leads to mis-regulation of gene expression. Embryos electroporated with morpholinos that interfere with Dicer splicing events (Fig. 5C ) were examined for Eya2 or Pax2 expression. Unlike the striking effects observed after electroporation of silencing vectors, reduction of Dicer did not affect Eya2 (Fig. 5A We further tested whether the expression of the gene silencing vectors affects Dicer expression levels: no changes were observed by RT-PCR (Fig. 5D, control primers) or by in situ hybridisation (not shown). To assess whether the side-effects observed are dependent on Dicer activity, we electroporated GFP silencing vectors together with Dicer morpholinos. However, all embryos transfected with both silencing tools showed the characteristic unspecific phenotypes described above (10/10; not shown). These results suggest that the side-effects caused by the pRFPRNAi expression are not due to competition for Dicer.
2.5.
Interferon responsive genes are unaffected by pRFPRNAi GFP expression
The interferon pathway functions as an initial defence mechanism against viral infection. Activation of this innate immune response is triggered partly by dsRNA, a common viral replicative intermediate (Sledz et al., 2003) . The resulting signalling cascade is mediated by a variety of proteins culminating in the induction of interferon-stimulated genes (ISGs; Pebernard and Iggo, 2004; Sledz et al., 2003; Witting et al., 2008) . Although unspecific activation of the interferon system through expression of silencing RNAs has so far not been reported in chick, in mammalian cells ISGs can be activated independently of interferon ligand (Sledz et al., 2003; Sledz and Williams, 2004) . p56 and FGF2 are two classic ISGs that Expression of Argonaute2 is almost identical to that of Drosha at this stage (not shown). Section planes are indicated by small arrows. For details see text. 1, Hensen's node; 2, ectoderm; 3, mesoderm; 4, endoderm; 5, primitive grove; 6, neural plate; 7, head mesoderm; 8, neural tube; 9, notochord; 10, neural crest cells; 11, head ectoderm; 12, prechordal mesoderm; 13, heart; 14, somite; 15, lateral plate mesoderm; 16, optic vesicle; 17, optic stalk; 18, dermomyotome; 19, otic cup.
are up-regulated following ds/shRNA treatment (Sledz and Williams, 2005) . Using a RT-PCR approach we examined the expression of p56 and FGF2 in chick tissue electroporated with the gene silencing vector pRFPRNAi GFP or the control vector pCAb-IRES-RFP. Amplicons for both transcripts are first detectable after the same number of PCR cycles irrespective of the vector. However, rather than up-regulation of p56 or FGF2 in the presence of the gene silencing vector we observed a slight reduction when compared with tissues expressing the control vector (Fig. 5D) . These results suggest that electroporation of the gene silencing vectors is unlikely to activate the interferon-stimulated genes p56 and FGF2.
pRFPRNAi GFP expression activates the p53 pathway and causes increased apoptosis
It has previously been reported that siRNA in mammalian cells and morpholinos in zebrafish (Robu et al., 2007; Scacheri et al., 2004) show off-target effects that lead to activation of the p53 pathway and increased apoptosis. We therefore investigated whether expression of pRFPRNAi GFP induces apoptosis using the TUNEL method. About 50% of pRFPRNAi GFP electroporated embryos show an accumulation of cells undergoing apoptosis (12/26; Fig. 6B and B 0 ). In contrast, when embryos expressing the control vectors pCAb-IRES-RFP (n = 11, Fig. 6A and A 0 ), pCAGGSeGFP (n = 5, not shown) or the pRFPRNAi backbone alone (n = 7, not shown) were analysed, no enhanced apoptosis was detected in electroporated tissues. In the absence of cellular stress, p53 protein is expressed at low steady-state levels and exerts little, if any, effect on cell fate (Ashcroft et al., 2000; Wang et al., 2003) . However, cellular stress can enhance its stability resulting in the accumulation of p53 protein (Bellamy et al., 1995; Hainaut, 1995; YonishRouach, 1996) . We therefore analysed p53 expression in pRFPRNAi GFP expressing tissue. We find that while low level of p53 protein is found in most cells, high expression levels are present in cells containing the GFP targeting pRFRNAi vector ( Fig. 6C- (Fig. 6D) . These results suggest that the morphological defects and gene mis-regulation observed with pRFPRNAi vectors is due to activation of the p53 pathway, which leads to apoptosis via PIG3 and CDM2 (Bose and Ghosh, 2007; Contente et al., 2002; LaFleur et al., 2002; Polyak et al., 1997) and cell cycle arrest via CIP1/p21 (Sherr and Roberts, 1995; Waldman et al., 1995) .
Discussion
Here we have evaluated different sequence-specific knockdown strategies in young chick embryos. We find that pRFPRNAi vectors, which use the cell intrinsic miRNA processing machinery to produce silencing RNAs cause non-specific, offtarget effects. Their expression in chick ectoderm results in target independent mis-regulation of gene expression and in morphological defects. Our results propose that activation of the p53 pathway is at least partially responsible through induction of CIP1/p21 and the pro-apoptotic genes CDM2 and PIG3. In contrast, morpholinos specifically reduce gene expression, but do not cause non-specific effects observed with pRFPRNAi vectors. Our data suggest that morpholinos are preferable for knock-down experiments in early chick embryos.
Involvement of the Dicer pathway?
The gene silencing system introduced by Das and colleagues (2006) was designed to allow processing of vector-derived transcripts by the same cellular machinery that is required for the processing of endogenous miRNA transcripts. The major components of this pathway include the ribonuclease-III family enzymes Drosha and Dicer, the nuclear export proteins Exportin-5 and RanGTP, and the RISC component Argonaute2. In the multi-step process yielding the mature miRNA, primary miRNA precursors (pri-miRNA) are first converted to pre-miRNA through cleavage by Drosha within the nucleus. Exportin-5 and RanGTP export pre-miRNA into the cytoplasm, where Dicer cuts it into 18-22 nt duplexes. One strand of the mature miRNA now enters the protein effector RISC, which mediates the degradation or translation inhibition of mRNA targets (Carrington and Ambros, 2003; Murchison and Hannon, 2004; Pillai, 2005) . The shRNA transcripts of the gene silencing vector are thought to undergo the same enzymatic cleavage described above to yield better silencing efficiency than expression of conventional double stranded RNA silencing molecules (Chang et al., 2006) . However, if any of the major pathway members are not present, exogenous shRNA may be processed inappropriately and cause toxic effects. This possibility is unlikely, since we show that the three main effectors of the miRNA pathway, Dicer, Drosha and Argonaute2, are expressed in the ectoderm of stage HH5-HH8 embryos.
At later stages, only Dicer is expressed in all tissues studied (otic placode, otic cup and neural tube), while Drosha and Argonaute2 are only detected in the neural tube. While it is possible that Drosha and Argonaute2 proteins remain stable once expressed in the early ectoderm (HH5-8), it is equally likely that at later stages Dicer associates with a different RISC to repress mRNA expression (Forstemann et al., 2007; Okamura et al., 2004; Tomari et al., 2007) . Nonetheless, our results suggest that components of the miRNA pathway are differentially expressed, which should be taken into account when designing shRNA-mediated knock-down experiments.
We speculated that Dicer may be expressed at a rate-limiting level, and that introduction of the vectors may cause competition with endogenous miRNA processing events that require this enzyme. However, Dicer knock-down with a morpholino does not mimic the consequences of gene silencing vectors, and the vectors themselves do not affect Dicer expression. Taken together, these results suggest that the non-specific effects of pRFPRNAi vectors are independent of the Dicer pathway.
3.2.
Involvement of the interferon pathway?
Although the interferon pathway has been implicated in mammalian innate immune response to small interfering RNA (Judge and Maclachlan, 2008; Sledz et al., 2003) , similar effects have so far not been described in the chick (Chesnutt and Niswander, 2004) . Our results do not provide support for the idea that ligand-independent activation of this pathway is a major cause of the non-specific pRFPRNAi effects. The expression of two major interferon responsive genes is not increased in tissues electroporated with the gene silencing vector. Recent studies reported that siRNA transfection results in the induction of only a subset of the 850 putative interferonstimulated genes (Sledz et al., 2003) . Since we do not know all of the responsive genes, the possibility of interferon mediated responses to pRFPRNAi expression cannot be excluded.
p53 activation and cell death as a consequence of pRFPRNAi vector expression
Previous studies have demonstrated off-target effects caused by introduction of siRNA and morpholinos in different experimental systems. In zebrafish, about 15% of morpholinos have been reported to cause neural cell death, which in turn is attenuated by p53 knock-down (Ekker and Larson, 2001; Robu et al., 2007) , suggesting that activation of the apoptotic pathway via p53 is involved in mediating such effects. Likewise, siRNA can cause changes in untargeted proteins like p53 and p21 (Scacheri et al., 2004) . Our results show that in young chick embryos introduction of pRFPRNAi vectors targeting a variety of genes including GFP leads to morphological defects, increased apoptosis, the stabilisation of p53 protein and the activation of its targets CDM2, PIG3 and CIP1/p21. CDM2 and PIG3 are known mediators of the apoptotic pathway (Bose and Ghosh, 2007; Contente et al., 2002; LaFleur et al., 2002; Polyak et al., 1997) and their activation is likely to account for the increased cell death observed. However, this increase does not appear to be sufficient to account for the complete loss of otic morphology and the dramatic changes in gene expression. We therefore suggest that in addition CIP1/p21-mediated cell cycle arrest is responsible for the non-specific effects observed.
Conclusion
Unlike pRFPRNAi, the morpholinos tested in this study do not show non-specific side-effects or activation of the p53 pathway. We have used five different morpholinos to alter the processing of newly synthesised transcripts (Schmajuk et al., 1999) . Two of them were designed to interfere with splicing events at different exon-intron boundaries of the primary mRNA of the nuclear factor Eya2. Another morpholino was designed to target splicing events in Dicer transcripts causing a frame-shift and generating a premature stop codon. Finally, Pax2 morpholinos targeted both the transcription start site and intron-exon junction. The use of fluoresceinconjugated morpholinos allows their visualisation within cells immediately after electroporation (and also appears to be required for successful electroporation; Voiculescu et al., 2008) . Although the morpholino is diluted due to cell division and disposal from cells (Heasman, 2002) , we were able to detect strong fluorescence for at least 24 h after electroporation. The morpholinos used in this study showed effective excision of the targeted exons, did not affect other transcripts or cell survival, nor was exon excision observed using standard control or sense morpholinos. Although we have not systematically tested the difference between pRFPRNAi or morpholino based knock-down strategies at later stages, we find that introduction of pRFPRNAi silencing vectors in the neural tube of HH11-12 embryos causes transcript mis-regulation similar to the effects observed in young embryos (Fig. S1 ). This observation suggests that the vector-based silencing system needs to be accompanied by careful controls also at later stages. In summary, we conclude that morpholinos are effective and specific and represent the preferred approach for knock-down studies in young chick embryos.
5.
Experimental procedures
Embryo culture and electroporation
Fertile hens' eggs (Winter Egg Farm, Hertfordshire, UK) were incubated in a humidified incubator at 38°C and staged according to Hamburger and Hamilton (HH; Hamburger and Hamilton, 1951) . Expression-vectors and fluorescein-coupled morpholinos were introduced into stage HH11 embryos using in ovo electroporation or into stage HH 4-6 embryos maintained in New culture (New, 1955; Stern and Ireland, 1981) using an electroporation chamber (McLarren et al., 2003) .
For in ovo electroporation eggs were windowed and injected with Indian ink (1:20) to reveal the embryo. Approximately 0.5 ll of gene-specific or control RNAi vector (1 lg/ll in 6% sucrose containing 0.1% fast green) was injected into the lumen of the anterior neural tube. A current of 25 V (5 pulses, 25 ms duration, 1 s interval) was applied across electrodes placed 3-4 mm apart on either side of the embryo using an IntraCel ISS10 pulse generator. After electroporation windows were sealed with insulation tape and the eggs incubated for 20 h.
Stages 4-6 embryos attached to the vitelline membrane were placed into an electroporation chamber (McLarren et al., 2003) and approximately 0.5 ll vector DNA (1 lg/ll in 6% sucrose containing 0.1% fast green) or morpholino (0.7 lM in 6% sucrose, 0.1% fast green containing 50 ng/ll pCAb-IRES-RFP DNA as 'carrier') was introduced between the vitelline membrane and the ectoderm. Using an IntraCel ISS10 pulse generator a current of 6 V (4 pulses, 50 ms duration, 1 s interval) was applied across the electrodes. After electroporation, embryos were maintained in New culture for 6-15 h at 38°C in a humid atmosphere. After incubation, embryos were fixed in phosphate-buffered saline (PBS) containing 4% paraformaldehyde and 2 mM EGTA for 4 h at room temperature before processing for in situ hybridisation.
5.2.
Whole mount in situ hybridisation, immunohistochemistry and TUNEL Embryos were processed for whole mount in situ hybridisation using digoxigenin (DIG)-labelled antisense RNA probes as previously described (Streit et al., 1998) . The DIG-labelled antisense riboprobes were generated from linearised plasmids encoding chick Argonaute2 (ChEST 531J17, ARK-Genomics, UK; Boardman et al., 2002) , BMP7 (Liem et al., 1995) , Dicer (ChEST716m22, ARK-Genomics), Dlx5 (Ferrari et al., 1995) , Drosha (ChEST1000b6, ARK-Genimics), Eya2 (Mishima and Tomarev, 1998) , GATA3 (Sheng and Stern, 1999) , GnRH (a gift from Dr. Ian Dunn), Notch1 (Myat et al., 1996) , Pax2 (a gift from M. Goulding), RALDH3 (a gift from Malcolm Maden), Six1 (a gift from Gillermo Oliver), Six4 (Esteve and Bovolenta, 1999) , Sox2 and -3 (a gift from Paul Scotting). NBT/BCIP (Roche, Switzerland) were used as substrates to detect transcripts. Stained embryos were photographed using an Olympus SZX12 stereomicroscope and an AxioCamHR digital camera (Zeiss, Germany). Morpholinos were detected by fluorescence or by using horseradish peroxidase (POD) conjugated monoclonal antibodies against fluorescein (Roche), while GFP expressing cells were revealed using polyclonal anti-GFP antibodies (1:1000; Molecular Probes). Immunofluorescence on whole mounts and cryosections was performed as previously described (Bhattacharyya et al., 2004; McLarren et al., 2003) , using polyclonal antibodies against mouse Pax2 (1:50; Zymed), monoclonal antibodies against Pax3, Pax6 (both Developmental Hybridoma Bank; 1:20) and p53 (Mab240 and Mab241, applied simultaneously, 1:100). Immunofluorescence staining with p53 was performed as described in Krinka et al., 2001 . The appropriate Alexafluor 488 (Molecular Probes) and Cy5 (Invitrogen) secondary antibodies were used in a 1:1000 dilution; nuclei were stained by DAPI (Molecular Probes). Cryosections were examined and photographed using a Zeiss Axiovert 200M, ORCA digital camera (Hamamatsu) and SimplePCI software (Digital Pixel, UK) or a Leica TCS SP5 confocal microscope.
The terminal deoxynucleotidyl transferase-mediated dUTP-DIG nick end labelling (TUNEL) method to reveal cells undergoing apoptosis was performed on fixed whole mount embryos. Embryos were rinsed in PBS containing 0.1% Tween (PBT), washed in PBT for 1 h and treated with 10 lg/ml Proteinase K in PBT for 20 min. Embryos were then post-fixed for 30 min in 4% formaldehyde, 0.1% glutaraldehyde in PBT, washed for 1 h in PBT and incubated for 30 min in terminal deoxynucleotidyl transferase (TdT) buffer (Invitrogen). This was followed by an overnight incubation of the embryos in TdT buffer containing 20 mM DIG-dUTP (Boehringer-Mannheim) and 50 U of TdT enzyme (Invitrogen) at room temperature. Embryos were washed twice in PBT for 1 h at 65°C and four times for 1 h at room temperature. Detection of the DIG-label was carried out following the in situ hybridisation protocol (Streit et al., 1998) .
5.3.
Vectors, morpholinos and primers
The RNAi vectors pRFPRNAi C, pRFPRNAi cNotch1 and pRFPRNAi GFP (Das et al., 2006) were supplied by ARK-Genomics, UK. RNAi target finder at https://genscript.com/ssl-bin/ app/rnai was used to select target sequences for Eya2 (G/ATA CCTTCCTACAGCATCAAA), and Pax2 (G/TCCTCGGTCGAATG GCGAGAA). Target sequences were cloned into the first hairpin site of the pRFPRNAi C silencing vector according to the ARK-Genomics protocol. All oligoprimers used (for sequences see protocol supplied by ARK-Genomics, UK; Das et al., 2006) were synthesised and supplied by Invitrogen. The avian expression vectors pCAb-IRES-mGFP/RFP (McLarren et al., 2003) and pCAGGSmCherry/eGFP (a kind gift from K. Langenfeld) were used as control vectors.
To down-regulate cDicer1 (NP_001035555.1), fluoresceincoupled morpholino (ACAGCTTACAACCTTACCTGTTTAG; Gene Tools, USA) targeting the exon 8-intron 9 boundary of cDicer1 were used. To reveal exon 8 excision (Fig. 5C ), RT-PCR was performed using primers spanning exon 5-exon 9 ( Table  2 ). The fluorescein-coupled standard control morpholino (Gene Tools, USA) was used for control experiments. Fluorescein-coupled morpholinos against Eya2 (ENS-GALG00000004508) were designed to interfere with splicing events at boundaries of exon 3-intron 4 (CTTGGCAGGAA CACTCACTTTGTTG) and exon 6-intron 7 (ATAAATGCTGAGA TATACCTGATGC), resulting in deletion of exon 3 and exon 6, respectively (Fig. 1A) . As control sense morpholinos and the standard control morpholino were used. RT-PCR was carried out to reveal exon excision (Table 2) . Fluorescein-coupled Pax2 morpholinos were generated to target the exon 2-intron 3 boundary (GCGGACTCGCCCTTACCTGTTTATG, using ENSG-ALT00000009124 Pax2 sequence) and the transcription start site (GGTCTGCCTTGCAGTGCATATCCAT, using NM_204793 Pax2 sequence), sense morpholinos were used as controls. Efficient knock-down of Pax2 was assessed by Pax2 antibody staining ( Fig. 3D-H) . To study expression of FGF2, p56, PIG3, CDM2, p21 and cS17 we used primers listed in Table 2 .
RT-PCR
Tissues expressing pRFPRNAi GFP, pCAb-IRES-RFP, morpholinos targeting Dicer, Eya2 or standard control morpholinos were excised from electroporated embryos after 16 h in culture. Electroporated ectoderm was visualised using a fluorescence stereomicroscope, freed from the underlying mesoderm using 20 lg/ml dispase (Roche) in Tyrode's saline and collected in Tri-reagent. RNA was extracted using the TriPure Isolation Kit (Roche) and reversed transcribed using random primers (Promega). PCR was carried out using 2 ll template and 0.3 U TaqPol (Promega) in a PTC-200 Peltier Thermal Cycler for 2 min at 94°C, 35 cycles of 94°C for 1 min, 1 min primer annealing temperature, and 45 s at 72°C. The final cycle step was followed by 12 min at 72°C.
